- citations in SCIndeks:
0
- citations in CrossRef:0
- citations in Google Scholar:[
 ]
- visits in previous 30 days:6
- full-text downloads in 30 days:0
|
|
|
2012, vol. 31, iss. 2, pp. 131-134
|
|
Prognostic value of high-sensitivity C-reactive protein and lipoprotein (a) in acute myocardial infarction patients receiving emergency percutaneous coronary intervention
Prognostička vrednost visokoosetljivog C-reaktivnog proteina i lipoproteina (a) kod pacijenata sa akutnim infarktom miokarda podvrgnutih hitnoj perkutanoj koronarnoj intervenciji
Department of Cardiology, Wuhan General Hospital, Guangzhou Military Command, PLA, Wuhan, China
email: [email protected]
Abstract
In order to study the prognostic value of highsensitivity C-reactive protein (hsCRP) and lipoprotein (a) [Lp(a)] in patients receiving emergency percutaneous coronary intervention (PCI) following acute myocardial infarction (AMI), we retrospectively reviewed 118 patients who received emergency PCI following AMI from January 2007 to April 2010. The plasma levels of hsCRP and Lp(a) were determined. The incidence of cardiovascular events was compared between patients with an elevated hsCRP level and those with a normal hsCRP level and between patients with an elevated Lp(a) level and those with a normal Lp(a) level. Results showed that the incidence of cardiovascular events was 52.9% in the hsCRP-elevated group and 18.2% in the hsCRP-normal group displaying a significant difference (P=0.011). However, the incidence of cardiovascular events was 35.3% in the Lp(a)-elevated group and 46.4% in the Lp(a)-normal group and statistical analysis revealed no significant difference (P=0.733). HsCRP, but not Lp(a), can serve as a prognostic factor for patients receiving emergency PCI following AMI.
Sažetak
Kako bi se utvrdila prognostička vrednost visokoosetljivog C-reaktivnog proteina (hsCRP) i lipoproteina (a) [Lp(a)] kod pacijenata podvrgnutih hitnoj perkutanoj koronarnoj intervenciji (PKI) posle akutnog infarkta miokarda (AIM), retrospektivno je analizirano 118 pacijenata podvrgnutih hitnoj PKI posle AIM između januara 2007. i aprila 2010. Određeni su nivoi hsCRP i Lp(a) u plazmi. Upoređena je incidenca kardiovaskularnih događaja kod pacijenata sa povišenim nivoom hsCRP i onih sa normalnim nivoom hsCRP, kao i između pacijenata sa povišenim nivoom Lp(a) i onih sa normalnim nivoom Lp(a). Rezultati su pokazali da je incidenca kardiovaskularnih događaja bila 52,9% u grupi sa povišenim hsCRP i 18,2% u grupi sa normalnim hsCRP, što je ukazalo na značajnu razliku (P=0,011). Međutim, incidenca kardiovaskularnih događaja bila je 35,3% u grupi sa povišenim Lp(a) i 46,4% u grupi sa normalnim Lp(a), a statistička analiza nije otkrila značajnu razliku (P=0,733). HsCRP, ali ne i Lp(a), može poslužiti kao prognostički faktor kod pacijenata podvrgnutih hitnoj PKI posle AIM.
|
|
|
References
|
|
1   
|
Boersma, E. (2006) Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. European Heart Journal, 27(7): 779-788
|
|
|
Kamstrup, P.R., Tybjaerg-Hansen, A., Steffensen, R., Nordestgaard, B.G. (2009) Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA, 301(22): 2331-9
|
|
|
Kones, R. (2009) The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease. Therapeutic advances in cardiovascular disease, 3(4): 309-15
|
|
|
le May, M.R., So, D.Y., Dionne, R., Glover, C.A., Froeschl, M.P.V., Wells, G.A., Davies, R.F., Sherrard, H.L., Maloney, J., Marquis, J., O'Brien, E.R., Trickett, J., Poirier, P. (2008) A citywide protocol for primary PCI in ST-segment elevation myocardial infarction. New England journal of medicine, 358(3): 231-40
|
|
1
|
Ortolani, P., Marzocchi, A., Marrozzini, C., Palmerini, T., Saia, F., Taglieri, N., Baldazzi, F., Silenzi, S., Bacchi-Reggiani, M.L., Guastaroba, P., Grilli, R., Branzi, A. (2008) Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention. European heart journal, 29(10): 1241-9
|
|
9
|
Pasceri, V., Willerson, J.T., Yeh, E.T. (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation, 102(18): 2165-8
|
|
6 
|
Petrović, D., Obrenović, R., Trbojević-Stanković, J., Majkić-Singh, N., Stojimirović, B. (2011) Cardiovascular mortality in hemodialysis patients: Clinical and epidemiological analysis. Journal of Medical Biochemistry, vol. 30, br. 4, str. 302-308
|
|
|
Shen, J., Ordovas, J.M. (2009) Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agents. Clinical chemistry, 55(2): 256-64
|
|
|
|
|